FINCH THERAPEUTICS GROUP, INC. Operating Expenses
FINCH THERAPEUTICS GROUP, INC. reported Operating Expenses of $6.11 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2024-08-13
- FINCH THERAPEUTICS GROUP, INC. operating expenses for the quarter ending 2024-06-30 was $6.11M, a 38.17% decline year-over-year.
- FINCH THERAPEUTICS GROUP, INC. operating expenses for the quarter ending 2024-03-31 was $5.20M, a 92.11% decline year-over-year.
- FINCH THERAPEUTICS GROUP, INC. operating expenses for the quarter ending 2023-12-31 was $4.42M, a 84.09% decline year-over-year.
- FINCH THERAPEUTICS GROUP, INC. operating expenses for the quarter ending 2023-09-30 was $3.78M, a 90.73% decline year-over-year.
- FINCH THERAPEUTICS GROUP, INC. operating expenses for fiscal 2023 was $83.97M, a 27.90% decline from fiscal 2022.
- FINCH THERAPEUTICS GROUP, INC. operating expenses for fiscal 2022 was $116.45M, a 48.32% increase from fiscal 2021.
- FINCH THERAPEUTICS GROUP, INC. operating expenses for fiscal 2021 was $78.52M, a 66.51% increase from fiscal 2020.
- FINCH THERAPEUTICS GROUP, INC. operating expenses for fiscal 2020 was $47.16M.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|
| 2024-06-30 | $6.11M 10-Q · filed 2024-08-13 | $11.31M 10-Q · filed 2024-08-13 | $15.72M derived: sum of 3 quarters · filed 2024-08-13 | $19.50M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2024-03-31 | $5.20M 10-Q · filed 2024-05-10 | $9.61M derived: sum of 2 quarters · filed 2024-05-10 | $13.39M derived: sum of 3 quarters · filed 2024-05-10 | $23.28M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-12-31 | $4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $8.20M derived: sum of 2 quarters · filed 2024-03-25 | $18.08M derived: sum of 3 quarters · filed 2024-08-13 | $83.97M 10-K · filed 2024-03-25 | |
| 2023-09-30 | $3.78M 10-Q · filed 2023-11-08 | $13.66M derived: sum of 2 quarters · filed 2024-08-13 | $79.55M 10-Q · filed 2023-11-08 | $107.31M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-06-30 | $9.88M 10-Q · filed 2024-08-13 | $75.77M 10-Q · filed 2024-08-13 | $103.53M derived: sum of 3 quarters · filed 2024-08-13 | $144.30M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $65.89M 10-Q · filed 2024-05-10 | $67.48M 10-Q · filed 2023-05-10 | $93.65M derived: sum of 2 quarters · filed 2024-05-10 | $134.42M derived: sum of 3 quarters · filed 2024-05-10 | $157.41M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $27.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $68.53M derived: sum of 2 quarters · filed 2024-03-25 | $91.52M derived: sum of 3 quarters · filed 2024-03-25 | $116.45M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $40.77M 10-Q · filed 2023-11-08 | $63.76M derived: sum of 2 quarters · filed 2023-11-08 | $88.69M 10-Q · filed 2023-11-08 | $108.56M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $22.99M 10-Q/A · filed 2023-08-11 | $47.92M 10-Q/A · filed 2023-08-11 | $67.79M derived: sum of 3 quarters · filed 2023-08-11 | $89.07M derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | $24.93M 10-Q · filed 2023-05-10 | $44.80M derived: sum of 2 quarters · filed 2023-05-10 | $66.08M derived: sum of 3 quarters · filed 2023-05-10 | $85.92M derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | $19.87M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $41.14M derived: sum of 2 quarters · filed 2023-03-23 | $60.99M derived: sum of 3 quarters · filed 2023-03-23 | $78.52M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $21.28M 10-Q · filed 2022-11-10 | $41.12M derived: sum of 2 quarters · filed 2022-11-10 | $58.65M 10-Q · filed 2022-11-10 | $73.59M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $19.85M 10-Q · filed 2022-08-11 | $37.37M 10-Q · filed 2022-08-11 | $52.31M derived: sum of 3 quarters · filed 2022-08-11 | $64.16M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $17.53M 10-Q · filed 2022-05-16 | $32.47M derived: sum of 2 quarters · filed 2022-05-16 | $44.32M derived: sum of 3 quarters · filed 2022-05-16 | $55.03M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $14.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $26.79M derived: sum of 2 quarters · filed 2022-03-31 | $37.50M derived: sum of 3 quarters · filed 2022-03-31 | $47.16M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $11.85M 10-Q · filed 2021-11-10 | $22.56M derived: sum of 2 quarters · filed 2021-11-10 | $32.22M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $10.71M 10-Q · filed 2021-08-10 | $20.36M 10-Q · filed 2021-08-10 | |||
| 2020-03-31 | $9.65M 10-Q · filed 2021-05-13 |